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Abstract
Loss of cardiomyocytes through cardiac injury and disease substantially impairs cardiac function. Given
that cardiomyocytes permanently exit the cell cycle soon after birth, the heart has traditionally been
considered a terminally differentiated organ, and thus unable to effectively regenerate. However, recent
discoveries have challenged this paradigm and have provided the foundation for exploring the prospect of
inducing cardiomyocytes to reenter the cell cycle and, in turn, regenerate damaged myocardium. This has
proven challenging, as mammalian cardiomyocytes appear to lose competency to respond robustly to
pro-proliferative stimuli following a neonatal maturation period. During this maturation period,
cardiomyocytes exit the cell cycle, undergo structural and metabolic changes, and most become
binucleated. We and others have observed that the small percentage of mature cardiomyocytes that
remain mononucleated (MoNuc) are more competent to respond to proliferative stimuli than their
binucleated (BiNuc) counterparts and therefore offer a biological model with which to interrogate loss of
proliferative competency in cardiomyocytes. We hypothesized that differences in the maturation
processes of MoNucs and BiNucs leave them differentially primed to respond to proliferative stimuli. We
devised a novel method to obtain populations highly enriched in MoNuc and BiNuc cardiomyocytes by
fluorescence associated cell sorting (FACS) and profiled the transcriptional differences between MoNuc
and BiNuc cardiomyocytes at three different timepoints spanning cardiomyocyte maturation.
Transcriptome analysis revealed that during the neonatal period, binucleation is associated with the
termination of a proliferation-associated gene expression program in exchange for a mature
cardiomyocyte gene expression program. Our data also suggested that an E2f/Rb transcriptional network
is central to the divergence of these two populations and that remnants of the differences acquired during
the neonatal period remain in adult cardiomyocytes. Furthermore, we induced binucleation by genetically
blocking the ability of cardiomyocytes to complete cytokinesis, which allowed us to directly link
binucleation to changes in Rb/E2f signaling and loss of regenerative competency. The research presented
in this dissertation suggests a potential mechanism by which the binucleation process may result in loss
of regenerative capacity.
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ABSTRACT

PROSPECTIVE ISOLATION AND CHARACTERIZATION OF
MONONUCLEATED AND BINUCLEATED CARDIOMYOCYTES
Rebecca Windmueller
Edward E. Morrisey
Loss of cardiomyocytes through cardiac injury and disease substantially impairs cardiac
function. Given that cardiomyocytes permanently exit the cell cycle soon after birth, the
heart has traditionally been considered a terminally differentiated organ, and thus unable
to effectively regenerate. However, recent discoveries have challenged this paradigm and
have provided the foundation for exploring the prospect of inducing cardiomyocytes to
reenter the cell cycle and, in turn, regenerate damaged myocardium. This has proven
challenging, as mammalian cardiomyocytes appear to lose competency to respond
robustly to pro-proliferative stimuli following a neonatal maturation period. During this
maturation period, cardiomyocytes exit the cell cycle, undergo structural and metabolic
changes, and most become binucleated. We and others have observed that the small
percentage of mature cardiomyocytes that remain mononucleated (MoNuc) are more
competent to respond to proliferative stimuli than their binucleated (BiNuc) counterparts
and therefore offer a biological model with which to interrogate loss of proliferative
competency in cardiomyocytes. We hypothesized that differences in the maturation
processes of MoNucs and BiNucs leave them differentially primed to respond to
vi

proliferative stimuli. We devised a novel method to obtain populations highly enriched
in MoNuc and BiNuc cardiomyocytes by fluorescence associated cell sorting (FACS)
and profiled the transcriptional differences between MoNuc and BiNuc cardiomyocytes
at three different timepoints spanning cardiomyocyte maturation. Transcriptome analysis
revealed that during the neonatal period, binucleation is associated with the termination
of a proliferation-associated gene expression program in exchange for a mature
cardiomyocyte gene expression program. Our data also suggested that an E2f/Rb
transcriptional network is central to the divergence of these two populations and that
remnants of the differences acquired during the neonatal period remain in adult
cardiomyocytes. Furthermore, we induced binucleation by genetically blocking the
ability of cardiomyocytes to complete cytokinesis, which allowed us to directly link
binucleation to changes in Rb/E2f signaling and loss of regenerative competency. The
research presented in this dissertation suggests a potential mechanism by which the
binucleation process may result in loss of regenerative capacity.
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CHAPTER 1: BACKGROUND AND APPROACH

1.1 INTRODUCTION
Acute myocardial infarction can result in the loss of upwards of one billion
cardiomyocytes (Murry et al., 2006). The adult mammalian heart is unable to effectively
replace these lost cardiac muscle cells, and instead, undergoes a maladaptive remodeling
process that includes hypertrophy and fibrotic scar formation. These events severely
impair the ability of the heart to generate force and can often progress to heart failure
(Braunwald and Bonow, 2012). Given its response to injury, the heart has traditionally
been considered a terminally differentiated organ, incapable of regeneration (Porrello and
Olson, 2014). However, as our understanding of cardiac biology has grown more
complex, this dogma has been increasingly challenged. The result has been the
emergence of the field of cardiac regeneration—the search for a means to replace
cardiomyocytes lost through injury.

1.2 APPROACHES TO CARDIAC REGENERATION
Several different schools of thought have materialized on how cardiac
regeneration may be facilitated. The research approaches taken can be generally
categorized by the potential source of replacement cardiomyocytes they investigate.
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Endogenous stem cells
Considerable effort has gone into determining whether a population of stem or
progenitor cells exists in the heart, analogous to the population of satellite cells
responsible for regenerating skeletal muscle (Beauchamp et al., 1999; Mauro, 1961).
Initial reports suggested a stem cell population, which could be identified by cell surface
expression of receptor tyrosine kinase c-kit, exists in the adult mammalian heart and is
capable of differentiating into new cardiomyocytes (Beltrami et al., 2003). While this
area of research has been clouded by controversy, a consensus now holds that these cells
do not represent a potential source for cardiomyocyte renewal (Eschenhagen et al., 2017;
Ozkan, 2019).

Exogenous stem cells
Another active area of research focuses on transplanting exogenously sourced
cardiac myocytes that have been differentiated from embryonic stem cells (ES cells) or
induced pluripotent stem cells (iPS cells) (Kehat et al., 2001; Mauritz et al., 2008). While
this approach is compelling, several significant roadblocks have come to light. Despite
efforts to optimize differentiation and maturation strategies, a significant challenge
remains that ES- and iPS-derived myocytes do not fully recapitulate mature myocytes.
Stem cell-derived cardiomyocytes resemble immature embryonic cardiomyocytes both
structurally and functionally and have reduced capacity for force generation, excitation2

contraction coupling, and energy production (Yang et al., 2014). However, it is not clear
whether the maturation state of transplanted cells affects their ability to integrate into a
recipient heart successfully. Upon transplantation into non-human primates, ES-derived
myocytes do appear to partially integrate into the myocardium but caused arrhythmias in
all treated animals (Chong et al., 2014). Therefore, the potential held by these cells to
contribute to cardiac regeneration remains to be determined.

Reprogramming of mature cells
The discovery that differentiated cells, such as fibroblasts, could be
reprogrammed into pluripotent cells through the expression of a set of transcription
factors, led to studies that examined whether fibroblasts could also be reprogrammed
directly into cardiomyocytes (Takahashi and Yamanaka, 2006). This strategy is intriguing
because it would utilize the cells responsible for fibrotic scar formation as a source of
new cardiomyocytes. A combination of four factors known to play critical roles in
cardiogenesis, Gata4, Mef2c, Tbx5, and Hand2, were subsequently identified to be able
to induce mouse cardiac fibroblasts to take on characteristics of cardiomyocytes (Ieda et
al., 2010; Qian et al., 2012). However, significant challenges that must be overcome
include low reprogramming efficiency and immature maturation state of induced
cardiomyocytes (Mohamed et al., 2017).

3

Proliferation of endogenous cardiomyocytes
During embryonic development, proliferation of cardiomyocytes contributes to
the growth of the heart, but soon after birth, cardiomyocytes of the mammalian heart exit
the cell cycle and switch to a hypertrophic mechanism of growth (Li et al., 1996; Oparil
et al., 1984). A final approach to cardiac regeneration is based on the premise of
developing therapies that reactivate the proliferation of endogenous cardiomyocytes to
regenerate damaged tissue. This approach sets the foundation for the research presented
in this dissertation.

1.3 PROLIFERATION AND REGENERATION IN THE HEART
Accumulating evidence has shown that in certain contexts, the heart is capable of
regeneration through the proliferation of endogenous cardiomyocytes. A number of lower
vertebrate and amphibian species, including zebrafish and newt, can fully regenerate
myocardium after experimental injuries as severe as apical resection (Oberpriller and
Oberpriller, 1974; Poss et al., 2002). Subsequent experiments utilized cardiomyocytespecific cmlc2a-Cre-Ert2 lineage tracing in the zebrafish heart to show that the formation
of new myocardium can be attributed to the proliferation of pre-existing cardiomyocytes
(Kikuchi et al., 2010; Jopling et al., 2010). During regeneration, cardiomyocytes were
observed to break down their sarcomere structure and express genes involved in the cell
cycle but did not appear to undergo extensive dedifferentiation.
4

Furthermore, the mammalian heart displays a robust regenerative capacity during
embryonic development (Drenckhahn et al., 2008; Sturzu et al., 2015). The murine heart
retains this ability through the early postnatal period (Porrello et al., 2011). In response to
apical resection of the heart at postnatal day 1, a-MHC-MerCreMer lineage traced
cardiomyocytes entered the cell cycle and were observed to disassemble the sarcomere
structure, mirroring the regenerative response observed in the zebrafish. However,
cardiomyocytes were not able to mount a regenerative response when the injury occurred
at postnatal day 7. This loss of regenerative response is concurrent with cardiomyocyte
cell cycle exit during the first week after birth. The neonatal mouse heart responds
similarly to an experimental injury model of myocardial infarction (Haubner et al., 2012).

Finally, several intriguing studies have been published noting the capacity of the
neonatal human heart to fully recover after infarction. In one case study, a newborn
presented with thrombotic occlusion of the left anterior descending artery within hours of
birth (Haubner et al., 2016). High serum levels of troponin T signified the death of
cardiomyocytes, and the child continued to show severe impairment of cardiac function
in the days immediately following thrombolysis and re-establishment of coronary blood
flow. However, by six weeks later, the child had regained complete cardiac function and
showed no signs of injury. In fact, children as old as twelve have shown complete
recovery of cardiac function after myocardial infarction (Celermajer et al., 1991).

5

While the regenerative ability of the heart appears to be lost over both
evolutionary and developmental time, the possibility of reactivating the regenerative
potential of the mammalian heart is supported by studies that show that a low level of
cardiomyocyte turnover does occur during the lifetime of both the mouse and human
(Mollova et al., 2013; Senyo et al., 2013). One study took advantage of a spike in
atmospheric levels of carbon-14 (14C) during nuclear bomb tests during the cold war to
age cardiomyocytes from deceased individuals (Bergmann et al., 2009). The investigators
isolated cardiac troponin-positive cardiomyocytes by FACS, extracted DNA, and
assessed levels of 14C in individuals born before and after the increase in 14C. They then
developed a mathematical model that suggested that new cardiomyocyte turnover does
occur, albeit at a low rate, over the human lifetime. Taken together, these observations
suggest that by understanding and modulating the mechanisms responsible for
cardiomyocyte proliferation and regeneration, we could potentially accelerate the
proliferation of cardiomyocytes for the regeneration of damaged tissue.

1.4 CARDIOMYOCYTE CELL CYCLE STUDIES
A large body of research has explored the possibility of experimentally
manipulating the proliferative dynamics of cardiomyocytes. These studies have largely
focused on modulating cell cycle regulators or growth factor pathways (Agah et al., 1997;
Engel et al., 2005; Liao et al., 2001; MacLellan et al., 2005; Poolman et al., 1999;
Soonpaa et al., 1997; Xiao et al., 2001). Several more recent studies have focused on the
6

Hippo pathway (Heallen et al., 2013; Leach et al., 2017; Tian et al., 2015; Xin et al.,
2013). A number of groups have reported increased cardiomyocyte proliferation, but the
responses largely do not appear to be robust enough for meaningful regeneration after
injury. However, these studies have revealed valuable insights into cardiomyocyte
proliferation that have guided ongoing research in the field, including the work presented
in this dissertation.

Cardiomyocytes face multiple barriers to cell cycle progression
Several early studies used transgenic models to modulate the expression of
individual cell cycle regulators and observed that in response, cardiomyocytes underwent
additional partial rounds of the cell cycle (Liao et al., 2001; Poolman et al., 1999).
Overexpression of cyclin D1 or c-Myc each resulted in DNA synthesis and increased
polyploidy and multinucleation in cardiomyocytes of the adult heart (Soonpaa et al.,
1997; Xiao et al., 2001). Overexpression of cyclin D1 also resulted in increased
cardiomyocytes size (hypertrophy). These observed phenotypes can result from
premature cell cycle exit (Figure 1.1) and suggest that cardiomyocytes underwent
additional rounds of DNA synthesis in response to stimuli but faced additional obstacles
that impeded completion of the cell cycle. Therefore, it appears that cardiomyocytes
experience barriers to division at multiple different stages of the cell cycle. These
observations also raise significant challenges in assessing cardiomyocyte proliferation.
7

Standard measures of cell proliferation, including measurements of BrdU incorporation
and stains for phosphorylated Histone H3 and Aurora B kinase, do not definitively mark
proliferating cardiomyocytes but instead only reveal how far into the cell cycle a
cardiomyocyte has progressed at a given time. This has remained a significant challenge
in the field. While no available technique conclusively shows cardiomyocyte
proliferation, the most rigorous assessments use a combination of BrdU incorporation
assays, cell cycle marker stains, and either quantification of increased cardiomyocyte
number in the heart or time-lapse imaging of dividing cardiomyocytes (Figure 1.2).

Proliferation and differentiation are linked
Later studies identified experimental strategies that led to more robust activation
of the cardiomyocyte cell cycle and, in doing so, also revealed new challenges. Hearts
deficient in pocket proteins Rb and p130 showed strong upregulation of several key cell
cycle regulators and contained cardiomyocytes positive for BrdU and phosphorylated
histone H3. However, these changes were accompanied by the expression of the
immature isoform of the myosin heavy chain (MHC) gene and decreased cardiac function
(MacLellan et al., 2005). Work from our lab showed that transgenic overexpression of the
microRNA family miR-302/367 activates the cardiomyocyte cell cycle at least in part
through repression of the Hippo pathway (Tian et al., 2015). However, prolonged
reactivation of the cell cycle also led to the expression of genes associated with immature
8

cardiomyocytes and a disorganized sarcomere structure. These indications of
dedifferentiation were accompanied by decreased cardiac function. In contrast, transient
delivery of miR-302/367 mimics resulted in improved cardiac function after injury. In
addition to the challenges they raise, these results also suggest that regulation of
proliferation and maturation of cardiomyocytes are closely linked.

Cardiomyocytes appear to lose competency to respond to proliferative stimuli
Studies have shown that the cardiomyocyte cell cycle can be reactivated in
response to several different experimental strategies. However, reported measurements of
DNA synthesis by BrdU incorporation suggest that an extremely limited proportion of
adult cardiomyocytes undergo even early stages of the cell cycle in response to these
stimuli (Figure 1.3). In several studies, however, early neonatal cardiomyocytes were
shown to respond more robustly to stimuli. Treatment of postnatal day 2 rat
cardiomyocytes with a combination of FGF1 and a p38 MAP kinase inhibitor resulted in
BrdU incorporation in approximately 80% of treated cardiomyocytes compared to 5% of
untreated cardiomyocytes. In contrast, when adult cardiomyocytes were treated with the
same conditions, approximately 4% of cells incorporated BrdU (Engel et al., 2005).
Similar trends resulted from stimulation with growth factor neuregulin1 or transgenic
overexpression of receptor tyrosine kinase ErbB4 (Bersell et al., 2009). These
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observations suggest that events occur during the neonatal period that act to shut off the
ability of cardiomyocytes to respond to proliferative stimuli.

Mononucleated cardiomyocytes retain increased proliferative competency
Two studies reported that a higher proportion of mononucleated cardiomyocytes
(MoNucs) than binucleated cardiomyocytes (BiNucs) reactivate the cell cycle in response
to proliferative stimuli (Bersell et al., 2009; Kuhn et al., 2007) (Figure 1.3). Our lab also
observed this trend as a result of adenoviral-mediated delivery of the miR-302/367
transcript to adult rat cardiomyocytes in vitro. While MoNucs comprise a small fraction
of adult rat cardiomyocytes, they were highly overrepresented in the cardiomyocytes that
responded to miR-302/367 (Figure 1.4). These data suggest that though mature
cardiomyocytes largely appear to lack competency to respond to proliferative stimuli,
MoNucs may represent a subset of cardiomyocytes with increased proliferative
competency. Moreover, these observations suggest that mononucleated and binucleated
cardiomyocytes could provide a biological model with which to interrogate loss of
proliferative competency.

The insights gained from these studies begin to piece together a picture of the
rules and roadblocks that govern cardiomyocyte proliferation. They also bring to light
many intriguing new questions. The research presented in this dissertation aims to
10

address some of these questions: 1) What events are responsible for the loss of
proliferative competency during the postnatal maturation period? 2) What are the
molecular differences underlying the distinct proliferative responses of MoNucs and
BiNucs? 3) Do differences in the maturation processes undergone by MoNucs and
BiNucs leave them differentially competent to respond to proliferative stimuli?

The remainder of this chapter will discuss our current understanding of the
relationship between binucleation, the postnatal maturation period, and the loss of
proliferative competency.

1.5 BINUCLEATION OF CARDIOMYOCYTES
During embryonic development, almost all cardiomyocytes are mononucleated,
which correlates with ongoing cardiomyocyte proliferation to drive organ growth. Soon
after birth, cardiomyocytes of the mammalian heart undergo a transition period associated
with cell cycle exit and maturation. During cell cycle exit, karyokinesis (nuclear division)
and cytokinesis (cytoplasmic division) become uncoupled in the murine heart.
Cardiomyocytes undergo a final round of DNA synthesis and nuclear division but do not
complete cytokinesis (Li et al., 1996). These events occur between postnatal days 4 and 7
and result in a high percentage of binucleated cardiomyocytes (Soonpaa et al., 1996).
After this period, only a small minority of cardiomyocyte remain mononucleated.
Between postnatal days 2 and 4, cardiomyocytes appear to lose their ability to fully
11

disassemble myofibrils during cell division and this has been proposed to be responsible
for failed cytokinesis and subsequent binucleation (Li et al., 1996). However, a different
study reported successful myofibril disassembly and instead suggested that failed
cytokinesis is the result of the mis-localization of the cytokinesis protein anillin (Engel et
al., 2006). The study suggested that improper localization of anillin results in the
disfunction of the actomyosin contractile ring responsible for carrying out cytokinesis.
Therefore, the events responsible for the binucleation of cardiomyocytes remain
incompletely resolved.

In recent years, new reports have provided further evidence that MoNucs retain
an increased potential to proliferate and to contribute to cardiac regeneration. Patterson et
al. characterized 120 different inbred mouse strains and found that the percentage of
diploid MoNucs in the heart varied from approximately 2% to 10%. The investigators
took advantage of this natural variation to show a positive correlation between the
percentage of MoNucs in the heart and the number of cells that re-enter the cell cycle
after injury as well as functional repair of the heart after injury (Patterson et al., 2017).
Another intriguing study used the zebrafish as a model, which retains a lifelong capacity
for cardiac regeneration and contains almost solely MoNucs under physiological
conditions. The authors of this study expressed a dominant-negative Ect2 in zebrafish
cardiomyocytes to induce polyploidy and binucleation and showed that it impaired the
heart’s ability to regenerate after injury (Gonzalez-Rosa et al., 2018). Despite these
12

intriguing observations, there have been no studies directly comparing MoNucs and
BiNucs in the mammalian heart, and the molecular basis for their distinct proliferative
responses remains unclear.

1.6 REGULATION OF CELL CYCLE EXIT
Cell cycle exit and maturation during the neonatal period are accompanied by
large scale, programmatic shifts in the gene expression profile of cardiomyocytes. Over
late embryonic development and through the postnatal period, a multitude of genes
involved in the cell cycle are downregulated, while those associated with cardiomyocytespecific processes are upregulated (Uosaki et al., 2015). The onset of cell cycle exit and
maturation can be altered to various degrees in response to experimental manipulation of
many different pathways that include Hippo, Rb/E2f, FGF, Myc, and Cdks/Cyclins
(Engel et al., 2005; MacLellan et al., 2005; Poolman et al., 1999; Tian et al., 2015; Xiao
et al., 2001; Xin et al., 2011). Therefore, it has remained a significant challenge to
determine the relative contributions of these different pathways to cell cycle exit,
binucleation, and loss of proliferative competency.

Cell cycle exit and maturation are tightly coupled to birth and have been proposed
to occur at least in part as a response to exposure to oxygen. The switch from a hypoxic
environment to an oxygen-rich environment results in reactive oxygen species
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production, which in turn activates a DNA damage response pathway (Puente et al.,
2014). It is this pathway that is thought to potentially initiate cell cycle exit and
mitochondrial biogenesis. In contrast, there is also evidence that pathways related to the
cell cycle and maturation begin to change expression levels during late embryonic
development (Uosaki et al., 2015). Therefore, the upstream events that initiate cell cycle
exit and maturation of cardiomyocytes remain incompletely resolved.

1.7 CARDIOMYOCYTE MATURATION
During the neonatal period, cell cycle exit and binucleation of cardiomyocytes are
accompanied by structural and metabolic changes that leave the heart better prepared to
meet the high physical and metabolic demands placed on it over the mammalian lifetime.
These changes may also not be conducive to cell division.

The sarcomere is the contractile unit of the cardiomyocyte and is composed of
actin and myosin along with a large number of proteins involved in scaffolding and
mechanotransduction. Repeating sarcomere units comprise myofibrils, which must break
down, at least in part, for cell division to occur (Ahuja et al., 2004). During neonatal
cardiomyocyte maturation, the sarcomere structure becomes more highly organized and
rigid, which allows it to generate more force (Jacot et al., 2010; Murphy, 1996; Siedner et
al., 2003). Changes in sarcomere organization and density are reflections of the
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upregulation and expression of alternate isoforms of sarcomere components (Lahmers et
al., 2004; Saggin et al., 1989). While myofibrils were observed to disassemble during cell
division in 2-day-old rat cardiomyocytes, they do not do so completely in cardiomyocytes
from 4-day-old rats (Li et al., 1996; Li et al., 1997). During cardiac regeneration in
zebrafish, proliferating cardiomyocytes transiently break down myofibrils (Jopling et al.,
2010). Therefore, the inability of the sarcomere structure to break down in mammalian
cardiomyocytes is thought to be a potential barrier to the completion of cytokinesis in
cardiomyocytes and to contribute to the formation of BiNucs during the postnatal period.

During embryonic development, cardiomyocytes utilize glycolytic metabolism for
energy. Within days after birth, there is a dramatic decrease in glycolysis as
cardiomyocytes switch to instead utilize fatty acid b-oxidation as the primary energy
source (Lopaschuk and Jaswal, 2010). This switch is accompanied by a marked increase
in mitochondrial mass and ultrastructural rearrangements that ensure myofibrils are
continuously able to receive a high supply of ATP (Piquereau et al., 2010). Interestingly,
rapidly proliferating cells, including cancer cells, have been found to rely primarily on
glycolytic metabolism (Warburg, 1925). It has been proposed that a proliferating cell may
require glycolysis because glycolytic intermediates provide the raw material for the
biosynthesis of nucleic acids, proteins, and lipids necessary to make a new cell (Lunt and
Vander Heiden, 2011). It is currently unknown whether a limited capacity for glycolytic
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metabolism in mature cardiomyocytes plays any role in restricting their ability to re-enter
the cell cycle.

1.8 MAINTENANCE OF THE TERMINALLY DIFFERENTIATED STATE
Widespread epigenetic changes occur during cardiomyocyte maturation and are
thought to maintain the mature state of cardiomyocytes after the neonatal period. DNA
methylation increases globally in cardiomyocytes over the neonatal period (Kou et al.,
2010). Furthermore, ATAC-seq has shown that promoters of genes associated with the
cell cycle become less accessible over cardiomyocyte maturation, while those associated
with sarcomere structure and metabolism become more accessible (Quaife-Ryan et al.,
2017). Genes that regulate DNA synthesis have been shown to acquire H3K9me3 and
H3K27me3 histone modifications and CpG methylation changes over cardiomyocyte
maturation (Gilsbach et al., 2018; Kou et al., 2010). While these changes are known to
occur over maturation, their role in inhibiting cardiomyocyte proliferation and
regeneration remains an area of active research.

1.9 HYPOTHESIS AND APPROACH
The research presented in this dissertation aims to further our understanding of the
mechanisms responsible for the loss of proliferative competency of cardiomyocytes. We
sought to gain insight into how the cell cycle is permanently shut off to better understand
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how we might turn it back on. We have employed mononucleated and binucleated
cardiomyocytes as a biological model of differential proliferative competency. The two
cardiomyocyte subsets diverge during a neonatal period associated with cell cycle exit,
maturation, and loss of regenerative capacity. We hypothesized that differences in the
maturation processes undergone by mononucleated and binucleated cardiomyocytes leave
them differentially primed to respond to proliferative stimuli. To address this hypothesis,
we characterized the transcriptional differences between the two subsets across
developmental time.
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Figure 1.1 The Cardiomyocyte Cell Cycle
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Figure 1.1 The Cardiomyocyte Cell Cycle
Cardiomyocytes can progress partially through the cell cycle and exit prematurely. Cells
that exit the cell cycle during G1 may be hypertrophic. Cells that undergo DNA synthesis
but do not complete mitosis become polyploid. Cells also may begin mitosis but exit the
cell cycle between karyokinesis and cytokinesis. This results in multinucleated cells.
Cardiomyocytes can exist in hypertrophic, polyploid, and multinucleated states under
physiological conditions but also as a result of pathological conditions or in response to
experimental stimuli.
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Figure 1.2 Reports of cell cycle progression in response to proliferative stimuli
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Figure 1.2 Reports of cell cycle progression in response to proliferative stimuli
Cardiomyocytes can partially progress through the cell cycle before prematurely exiting.
Therefore, the data shown here does not show true cardiomyocyte proliferation but
instead how far in the cell cycle the cardiomyocyte has been able to progress at a given
time. The furthest point in the cell cycle reported for different pro-proliferative stimuli
are shown. (Bersell et al., 2009; Engel et al., 2005; Heallen et al., 2013; Kuhn et al.,
2007; Lavine et al., 2005; Liao et al., 2001; Pasumarthi et al., 2005; Soonpaa et al., 1996;
von Gise et al., 2012; Xiao et al., 2001)
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Figure 1.3 Reports of DNA synthesis in response to proliferative stimuli
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Figure 1.3 Reports of DNA synthesis in response to proliferative stimuli
Reported measures of BrdU incorporation in adult cardiomyocytes in response to
proliferative stimuli are shown in pink. Typical percentages of cycling cardiomyocytes in
the embryonic heart reported in the literature are shown in purple for comparison. Data
shows that the majority of cardiomyocytes fail to undergo even early stages of the cell
cycle in response to proliferative stimuli. Two studies report that a higher percentage of
mononucleated cardiomyocytes than binucleated cardiomyocytes reactivate the cell
cycle. (Bersell et al., 2009; Engel et al., 2005; Heallen et al., 2013; Kuhn et al., 2007;
Lavine et al., 2005; Liao et al., 2001; Pasumarthi et al., 2005; Soonpaa et al., 1996; von
Gise et al., 2012; Xiao et al., 2001)
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Figure 1.4 MoNucs are overrepresented in cardiomyocytes that respond to miR302/367
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Figure 1.4 MoNucs are overrepresented in cardiomyocytes that respond to miR302/367
Measures of cell cycle activation by immunostaining 6d after in vitro adenoviral
mediated infection of the miR-302/367 transcript in freshly isolated rat cardiomyocytes.
Percentages are reported as cell staining positive for the specified cell cycle reporter out
of total cells staining positive for cardiomyocyte marker Sarcomeric a-actinin. Taking
into account that only ~10% of adult murine cardiomyocytes are mononucleated, this
data shows MoNucs are overrepresented in the cardiomyocytes that respond to
proliferative stimuli.
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CHAPTER 2: DIRECT COMPARISON OF MONONUCLEATED AND
BINUCLEATED CARDIOMYOCYTES REVEALS MOLECULAR
MECHANISMS UNDERLYING DISTINCT PROLIFERATIVE
COMPETENCIES

2.1 SUMMARY
Several reports have demonstrated that mononucleated (MoNuc) cardiomyocytes
are more responsive to pro-proliferative stimuli than are binucleated (BiNuc)
cardiomyocytes. However, techniques to isolate and characterize these two different
cardiomyocyte populations have been lacking. To address whether the developmental
divergence of MoNucs and BiNucs contributes to their differential response to
proliferative stimuli, we developed a novel strategy to separate MoNuc and BiNuc
cardiomyocytes using fluorescence-activated cell sorting (FACS). We assessed the
transcriptional differences between these subsets of cardiomyocytes across late
development and in the adult. These data revealed that during the neonatal period,
binucleation is associated with the silencing of genes that permit the onset of DNA
synthesis, specifically those that are targets of the E2f transcription factor family, and the
upregulation of a set of genes involved in cardiomyocyte maturation. Remnants of the
differences between MoNucs and BiNucs established during the neonatal period remain
at the adult stage. Furthermore, we showed that Rb is required for the down-regulation of
E2f target genes that we observed to occur.
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2.2 MONONUCLEATED AND BINUCLEATED CARDIOMYOCYTES CAN BE
SEPARATED BY FACS
We sought to characterize transcriptional differences between MoNuc and BiNuc
cardiomyocytes during maturation from late embryonic development through adulthood.
Single-cell suspensions were prepared from hearts at the indicated timepoints to be sorted
by FACS (Figure 2.1A). A wide nozzle was used to accommodate the large size of
mature cardiomyocytes. A wide nozzle also subjects the cardiomyocytes to lower shear
stress than is typical for FACS (Shapiro, 1985). Ventricular cardiomyocytes were lineage
labeled with Mlc2vcre:R26REYFP, and nuclei were stained with VybrantTM DyeCycleTM
DNA dye. The intensity of the fluorescent signal emitted by this dye is proportional to the
DNA quantity. The dye is used to assess DNA content and ploidy of nuclei by FACS
(Patterson et al., 2017). Cells were gated on EYFP presence then determined to be
MoNucs or BiNucs by a strategy that combines the use of DyeCycleTM dye with the
concept behind doublet discrimination (Figure 2.1B). Doublet discrimination is used in
FACS analysis to exclude instances where two cells are stuck together and are therefore
characterized as a single event. Doublet discrimination takes into account the width
(time), and the height (voltage intensity) of the signal produced and assumes that two
cells will produce a signal of greater width than a single cell, while the height of the
signal will remain the same. We utilized a similar metric to distinguish BiNucs from
MoNucs. Nucleation was gated on the height and width of the fluorescent signal
produced by 405nm laser excitation of DyeCycleTM dye. (Figure 2.2A-C). The nuclei of
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BiNucs produced a signal of equal intensity to that produced by diploid MoNucs but of
greater width. MoNucs with increased voltage intensity, presumed to be polyploid or
undergoing DNA synthesis, were excluded. Since the size and shape of cardiomyocytes
change over maturation, each timepoint required tailored gating parameters. These
parameters were empirically fine-tuned to maximize enrichment by sorting cells onto
microscope slides for visualization of nucleation (Figure 2.2D-I). The relative
percentages of MoNucs and BiNucs collected at each timepoint faithfully reflects the
developmental switch to BiNucs being the predominant cardiomyocyte subtype, and
agree with reported percentages of MoNucs and BiNucs over cardiomyocyte maturation
(Ikenishi et al., 2012). This methodology resulted in greater than 70% enrichment of
either MoNucs or BiNucs at the E18.5 timepoint and greater than 90% enrichment at the
P7 and adult timepoints (Figure 2.2J-L). We quantified the viability of sorted
cardiomyocytes by propidium iodide (PI) staining. At each timepoint, >97% of cells
remained negative for PI after being sorted (Figure 2.3A-B). Finally, we expanded the
application of our FACS strategy to separate adult MoNucs and BiNucs without the
requirement of a lineage marker (Figure 2.4A). We reasoned that a long rod-shaped
cardiomyocyte would produce a wider light scatter than a smaller round non-myocyte,
similar to our gating for two nuclei versus one. To quantify the ability of this strategy to
identify cardiomyocytes accurately, we gated lineage traced cells on the width of side
scatter and then backgated on YFP fluorescence, showing that 99.1% of cells identified
are cardiomyocytes by their YFP expression (Figure 2.4B-C). Importantly, we were able
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to separate MoNucs and BiNucs by their distinct light scatter with equal success rates
using this strategy (Figure 2.4D-E). Together, the techniques described here allowed us to
isolate highly enriched populations of lineage labeled MoNuc and BiNuc cardiomyocytes
from E18.5, P7, and adult mice to assess changes in gene expression during
cardiomyocyte maturation.

2.3 BINUCLEATION IS ACCOMPANIED BY A SWITCH FROM A
PROLIFERATION- TO MATURATION-ASSOCIATED GENE EXPRESSION
PROGRAM
To characterize transcriptional differences between MoNucs and BiNucs over the
neonatal maturation period, we sorted MoNuc and BiNuc cardiomyocyte populations and
performed RNA-seq analysis. The Principal Component Analysis (PCA) shows that at
each timepoint, MoNucs and BiNucs are transcriptionally distinct with the primary and
secondary components accounting for 76.2% and 9.6% respectively of the variance
across all of the samples (Figure 2.5A). At E18.5, BiNucs were enriched for genes
involved in cell division, including several genes known to be involved in cytokinesis
(Figure 2.6). This data suggests that at this timepoint, cardiomyocytes identified as
BiNucs may have still been undergoing or attempting to undergo cytokinesis. The RNAseq data revealed that MoNucs and BiNucs exhibit the most statistically significant
differences in gene expression at P7. To further characterize the set of genes differentially
expressed between P7 MoNucs and BiNucs, we examined their expression levels across
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all samples. (Figure 2.7A). We observed that the expression of this set of genes also
changes significantly between the embryonic and adult timepoints. The genes
upregulated in P7 MoNucs tend to be more highly expressed in both embryonic
cardiomyocyte populations compared to adult cardiomyocytes, whereas the genes
upregulated in P7 BiNucs tend to be enriched in both adult cardiomyocyte populations
versus embryonic cardiomyocytes. Gene set enrichment analysis (GSEA) showed that P7
MoNucs are enriched for genes involved in the cell cycle, especially those that are E2f
targets and those involved in DNA synthesis (Figure 2.7B, Figure 2.8A-B, Table 2.1). In
contrast, P7 BiNucs are enriched for genes involved in cardiomyocyte maturation
processes, including sarcomere organization and a switch to fatty acid oxidative
metabolism (Figure 2.7B, Figure 2.8C-D, Table 2.2). Together, this data indicates that
during the postnatal period, cardiomyocyte binucleation is accompanied by the
termination of the fetal gene expression program, including genes required for
proliferation, in exchange for activation of the mature cardiomyocyte gene expression
program.

2.4 BINUCLEATED CARDIOMYOCYTES AT P7 TURN OFF E2F TARGET GENE
EXPRESSION REQUIRED FOR G1/S PHASE TRANSITION
Transcriptome analysis revealed that at P7, binucleation is accompanied by the
termination of a gene expression program closely associated with regulating the onset of
proliferation. To gain insight into which transcription factors may be involved in
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regulating the apparent switch in transcription program, we analyzed the promoters of
differentially expressed genes at P7 for the enrichment of DNA binding sites and
associated transcription factors. This analysis revealed that binucleation is accompanied
by down-regulation of targets of the E2f transcription factor family, whereas genes
upregulated in P7 BiNucs are targets of the Ppara, Esrra, Mef2, and Myod transcription
factors (Figure 2.9A). The E2f transcription factor family is known to control the onset of
DNA synthesis (Nevins, 1992). Our RNA-seq data shows that 54% of the top 50 downregulated genes in P7 BiNucs are targets of E2f that are known to regulate the G1/S
transition and onset of DNA synthesis (Figure 2.9B, C). This down-regulation occurs
most dramatically between P7 MoNucs and BiNucs (Figure 2.10A). In addition to their
target genes, four of the E2f family members, E2f1, E2f2, E2f7, and E2f8, were strongly
down-regulated in P7 BiNucs (Figure 2.10B). These data demonstrate that DNA
synthesis and onset of the cell cycle is dramatically down-regulated in association with
binucleation in P7 cardiomyocytes, through silencing of E2f target genes.

2.5 ADULT MONONUCLEATED AND BINUCLEATED CARDIOMYOCYTES
RETAIN DIFFERENCES ESTABLISHED DURING NEONATAL MATURATION
To determine whether differences between P7 MoNucs and BiNucs remained in
adult cardiomyocytes, we compared the transcriptional profiles of MoNucs and BiNucs
from adult hearts. Transcriptionally, these cardiomyocyte subsets are quite similar, with
only three differentially expressed genes with an FDR < 0.05 (Figure 2.11A). However,
31

two of these genes, Necdin and Cenpf, are known to be involved in the regulation of
E2f/Rb signaling (Papadimou et al., 2005; Taniura et al., 1998). 456 genes had a nonadjusted p-value < 0.05 (Figure 2.11B). GSEA of these genes revealed enrichment of
categories related to those that are differentially expressed between P7 MoNucs and
BiNucs (Figure 2.11C, Table 2.3). While adult MoNucs are enriched for genes involved
in DNA synthesis and G2 phase of the cell cycle, adult BiNucs are enriched for genes
involved in fatty acid oxidation. Furthermore, several of the most highly downregulated
E2f target genes in the P7 BiNucs remain downregulated in the Adult BiNucs (Figure
2.11D). Together, this data shows that adult MoNucs and BiNucs retain remnants of
transcriptional differences established during the neonatal maturation period.

To further examine differences between adult MoNucs and BiNucs, we performed
transmission electron microscopy studies on sorted cardiomyocytes. We observed that
adult BiNucs have a significantly higher density and buildup of glycogen granules
surrounding the mitochondria than do MoNucs (Figure 2.12A-B). Glycogen granules are
a stored energy source that is depleted when used to drive glycolytic metabolism (Prats et
al., 2018; Schneider et al., 2014). This observation suggests that metabolic differences
exist between adult MoNucs and BiNucs. One possible explanation for this observation is
that diploid adult MoNucs may utilize glycolytic metabolism more readily than BiNucs
and are therefore not able to maintain stores of excess glycogen. This would be consistent
with the switch away from glycolytic metabolism that occurs during cardiomyocyte
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maturation and the oxidative metabolism gene expression profile that we observed to be
enriched in BiNucs at the P7 and adult stages. These data further support the concept that
adult MoNucs and BiNucs retain remnants of differences established during the neonatal
maturation period.

2.6 RB IS REQUIRED FOR DOWNREGULATION OF E2F TARGET GENES
E2f activity is known to be regulated by Rb, and this interaction can have
temporary, as well as long term control over entry into S phase of the cell cycle
(Harrington et al., 1998; Lundberg and Weinberg, 1998; Nevins, 1992). Previous work
has shown that Rb family members are required for cell cycle exit of cardiomyocytes
during the postnatal period (MacLellan et al., 2005). Furthermore, Rb recruits HP1-g to
H3K9me3 marks at a subset of E2f target genes to stably repress their expression during
cardiomyocyte maturation (Sdek et al., 2011). Therefore, we sought to determine whether
Rb is required for the repression of E2f target genes that we saw to be depleted in P7
BiNucs. We utilized a triple Rb family knockout mouse model,
Rbflox/flox;p130flox/flox;p107-/- (Viatour et al., 2008) to determine the role of the Rb family
in cardiomyocyte binucleation. Cardiomyocytes were isolated from P1 mice and infected
with either adenoviral-Cre/GFP (TKO) or adenoviral-GFP (control) in vitro (Figure
2.13A). QPCR revealed strong downregulation of the Rb1 transcript in TKO
cardiomyocytes (Figure 2.13B). We then quantified the percentage of GFP+ MoNucs and
BiNucs in both control and TKO samples to determine whether Rb activity regulates the
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onset of binucleation. There was no difference in the ratio of BiNucs to MoNucs between
control and TKO cardiomyocytes (Figure 2.13C-D). QPCR revealed that TKO
cardiomyocytes strongly upregulated E2f target genes whose expression are decreased in
P7 BiNucs versus MoNucs (Figure 2.13E). In contrast, non-E2f targets were upregulated
to a lesser degree in TKO cardiomyocytes (Figure 2.13E-F). Together this data suggests
that Rb is required for down-regulation of E2f target genes in neonatal cardiomyocytes
and that Rb mediated changes in E2f target expression are not responsible for the onset of
binucleation.
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Figure 2.1 Schematic of MoNuc and BiNuc sorting strategy
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Figure 2.1 Schematic of MoNuc and BiNuc sorting strategy
(A) Schematic of experimental design to collect mononucleated (MoNucs) and
binucleated (BiNucs) cardiomyocytes for RNA-sequencing analysis. Single-cell
suspensions are isolated from the hearts of Mlc2vcre:R26REYFP mice at age E18.5, P7, and
adult. Nuclei are stained with VybrantTM DyeCycleTM DNA dye. Cardiomyocytes are
identified by FACS as YFP+ and then sorted by nucleation. (B) Schematic of sorting
strategy for separating MoNucs and BiNucs. As nuclei of cardiomyocytes pass the 405
nm laser, DyeCycleTM DNA dye is activated and produces a signal of which the width is
proportional to the length of time the nuclei travel through the laser. Two nuclei (BiNucs)
take longer to travel past the laser than one nucleus (MoNucs) and produce two
overlapping signals, which are interpreted as a single signal of greater width. The height
of the signal produced is proportional to DNA content per nucleus, allowing the separate
gating of diploid and polyploid cells. MoNucs and BiNucs, cluster separately on a plot of
width versus height of the 405 signal.
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Figure 2.2 Results of FACS sorting to separate MoNucs and BiNucs
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Figure 2.2 Results of FACS sorting to separate MoNucs and BiNucs
(A-C) Representative flow cytometry plots of the width versus height of the 405 channel.
Gates used to sort E18.5 (A), P7 (B), and adult (C) MoNucs and BiNucs are shown.
Mean percentages of total YFP+ cells that fall inside MoNuc or BiNuc gates are
indicated. n=3 animals for each timepoint. (D-I) Cropped images of live
Mlc2vcre:R26REYFP MoNucs (D, F, H,) and BiNucs (E, G, I) sorted onto slides according
to gates shown in (A-C). Scale bar, 50 μm. (J-L) Percentages of cells correctly and
incorrectly sorted into indicated groups as determined by slide images taken during sorts.
>100 cells were counted for each group.
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Figure 2.3 Validation and Viability of FACS methods
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Figure 2.3 Validation and Viability of FACS methods
(A) Viability testing of FACS sorted cardiomyocytes. Cropped images of live E18.5, P7,
adult Mlc2vcre:R26REYFP MoNucs and BiNucs stained with Propidium Iodide.
Cardiomyocytes gated on negative Propidium iodide staining were sorted onto slides
according to gates shown in (Figure 2.1 A-C) and imaged to determine levels of cell
death associated with the sorting process. Scale bar, 200 μm. (B) Quantification of
percentages of cells staining positive and negative for Propidium iodide after FACS
sorting. >100 cells were counted per group.
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Figure 2.4 Expanded FACS strategy allows the sorting of cardiomyocytes without a
lineage marker
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Figure 2.4 Expanded FACS strategy allows the sorting of cardiomyocytes without a
lineage marker
(A) Adult CD-1 MoNuc and BiNuc cardiomyocytes sorted onto slides with expanded
FACS strategy. Scale bar, 50 μm (B) FACS plots showing expanded FACS strategy. (C)
The success of the expanded FACS strategy tested on Mlc2vcre:R26REYFP
cardiomyocytes. Histogram showing >99% of cells gated as cardiomyocytes are YFP+.
(D) Testing relative ability of expanded FACS strategy to identify MoNucs and BiNucs
as cardiomyocytes. FACS plot showing further gating of the cardiomyocytes identified in
(B) to separate MoNucs and BiNucs. (E) Histograms showing lineage tracing of
identified MoNucs and BiNucs. >99% of both MoNucs and BiNucs identified as
cardiomyocytes by their light-scattering properties were YFP positive.
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Figure 2.5 MoNucs and BiNucs are transcriptionally distinct at all analyzed
timepoints
(A) Principal component analysis (PCA) from RNA-seq of MoNucs and BiNucs from
E18.5, P7, and adult hearts shows that at each timepoint, MoNucs and BiNucs are
transcriptionally distinct. n=3 animals per timepoint
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Figure 2.6 RNA seq analysis of E18.5 MoNucs versus BiNucs
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Figure 2.6 RNA seq analysis of E18.5 MoNucs versus BiNucs
(A) Heatmap of top 50 differentially expressed genes in E18.5 MoNucs versus BiNucs.
(B) Representative categories from gene set enrichment analysis (GSEA) of differential
gene expression between E18.5 MoNucs and BiNucs. Analysis was done using Camera.
Results suggest that at E18.5, cardiomyocytes collected as BiNucs are likely still in the
process of cytokinesis.
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Figure 2.7 At P7, binucleation is accompanied by a switch from a proliferationassociated gene expression program to one associated with maturation
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Figure 2.7 At P7, binucleation is accompanied by a switch from a proliferationassociated gene expression program to one associated with maturation
(A) Heatmaps of genes with significant differences (FDR < 0.05) in expression between
P7 MoNucs and BiNucs. Gene expression values are represented at P7 only (top) and at
all timepoints (bottom). The bottom heatmap reveals that the gene expression profile of
P7 BiNucs but not P7 MoNucs shows resemblance to profiles of adult samples. The
difference in intensity between the top and bottom heatmaps is due to the different scales
used. (B) Representative categories from gene set enrichment analysis (GSEA) of
differential gene expression between P7 MoNucs and BiNucs. P7 MoNucs are enriched
for genes involved in the cell cycle, while P7 BiNucs are enriched for genes involved in
cardiomyocyte maturation. Analysis was done using Camera.
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Figure 2.8 Heatmaps of genes included in GSEA categories
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Figure 2.8 Heatmaps of genes included in GSEA categories
(A-D) Heatmaps of gene sets included in Figure 2.7. E2f target gene heatmap shows the
top 50 differentially expressed genes from the set of 199 genes.
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Figure 2.9 Binucleated cardiomyocytes at P7 turn off E2f target gene expression
required for the G1/S phase transition and S phase
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Figure 2.9 Binucleated cardiomyocytes at P7 turn off E2f target gene expression
required for G1/S phase transition and S phase
(A) Enriched transcription factor motifs within promoters of genes differentially
expressed between P7 MoNucs and BiNucs reveals E2f target genes are most highly
enriched. Analysis was performed using the Toppgene suite. (B) Analysis of the top 50
differentially expressed genes between P7 MoNucs and BiNucs reveals 66% (33/50) are
involved in G1/S transition and S phase of the cell cycle, 27 of which (54%, 27/50) are
E2f target genes. (C) Gene set enrichment analysis plot of E2f target genes differentially
expressed between P7 MoNucs and BiNucs.
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Figure 2.10 E2f target gene expression decreases specifically between P7 MoNucs
and BiNucs
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Figure 2.10 E2f target gene expression decreases specifically between P7 MoNucs
and BiNucs
Expression values of (A) E2f target genes and (B) indicated E2f family members and are
shown across all samples. Significance of differences in gene expression between E18.5
and P7 MoNucs and between P7 MoNucs and BiNucs are indicated. Data are mean ±
SEM. n=3 animals per timepoint. p-values are determined by student’s t-test. ns=not
significant, *=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001.
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Figure 2.11 Adult mononucleated and binucleated cardiomyocytes retain differences
established during neonatal maturation
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Figure 2.11 Adult mononucleated and binucleated cardiomyocytes retain differences
established during neonatal maturation
(A) Expression values measured by RNA-seq of genes with FDR < 0.05 between adult
MoNucs and BiNucs. Data are mean ± SEM. n=3 animals
per timepoint. (B) Heatmap of gene expression differences with p-value < 0.05 between
Adult MoNucs and BiNucs. (C) Representative categories from gene set enrichment
analysis (GSEA) of differential gene expression between Adult MoNucs and BiNucs
reveals overlap with categories enriched between P7 MoNucs and BiNucs. Analysis was
done using Camera. (D) A subset of E2f target genes most differentially expressed
between P7 MoNucs and BiNucs remain differentially expressed between Adult MoNucs
and BiNucs. The expression values of these genes are shown in P7 and Adult samples.
Significance of differences in gene expression between P7 MoNucs and BiNucs and
between Adult MoNucs and BiNucs are indicated. Data are mean ± SEM. n=3 animals
per timepoint. p-values are determined by student’s t-test. ns=not significant, *=p<0.05,
**=p<0.01, ***=p<0.001, ****=p<0.0001.
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Figure 2.12 Adult BiNucs have a higher density of glycogen granules
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Figure 2.12 Adult BiNucs have a higher density of glycogen granules.
(A) Electron micrographs of sorted adult MoNucs and BiNucs. Scale bar, 1 μm. (B)
Quantification of glycogen granule density in non-sarcomeric cytoplasmic space
visualized by electron microscopy. Significance of difference between adult MoNucs and
BiNucs is indicated Data are mean ± SEM. n=5 cells per sample. p-values are determined
by student’s t-test. ns=not significant, *=p<0.05, **=p<0.01, ***=p<0.001,
****=p<0.0001.
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Figure 2.13 Rb acts downstream of binucleation and is required for downregulation
of E2f target genes

58

Figure 2.13 Rb acts downstream of binucleation and is required for downregulation
of E2f target genes
(A) Schematic of experimental design of in vitro Rb family knockout experiments.
Cardiomyocytes were isolated from Rbflox/flox;p130flox/flox;p107-/- mice at P1 and infected
with adenovirus containing either Cre and GFP (Ad-Cre/GFP) or GFP alone (Ad-GFP).
Cells infected with Ad-Cre/GFP are denoted as Triple Knockout (TKO) samples, and
cells infected with Ad-GFP are denoted as Control samples. (B) Expression values of the
Rb transcript in TKO samples compared to control samples by qPCR. Data are mean ±
SEM. n=5 animals. (C) Confocal images of fixed TKO MoNuc and BiNuc
cardiomyocytes stained with antibodies against α-actinin and GFP. Scale bar, 20 μm. (D)
Quantification of the ratio of BiNucs to MoNucs and percentages of MoNucs and BiNucs
in GFP+ control and TKO cardiomyocytes fixed and stained with antibodies against αactinin and GFP. n=3 animals. Data are mean ± SEM. p-values are determined by
student’s t-test (E) Gene expression differences between Control and TKO samples of
E2f target genes and non-E2f target genes by qPCR. Data are mean ± SEM. n=5 animals.
p-values are determined by student's t-test. (F) Comparison of mean fold change
expression of TKO samples over control samples of E2f target genes versus non-E2f
target genes. p-values are determined by student's t-test. ns=not significant, *=p<0.05,
**=p<0.01, ***=p<0.001, ****=p<0.0001.
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Table 2.1 Top 10 upregulated Gene Ontology and Hallmark categories at P7
(Enriched in MoNucs at P7)
GO Category

Direction

GO:0006261 DNA-dependent DNA replication

Up

2.18E-27

3.27E-23

GO:0005657 replication fork

Up

4.05E-26

3.03E-22

GO:0006270 DNA replication initiation

Up

6.45E-26

3.22E-22

GO:0006260 DNA replication

Up

2.02E-23

7.56E-20

GO:0042555 MCM complex

Up

3.99E-17

1.19E-13

GO:0030894 replisome

Up

2.48E-15

6.20E-12

GO:0007059 chromosome segregation

Up

4.44E-15

9.50E-12

GO:0000793 condensed chromosome

Up

7.72E-15

1.45E-11

GO:0043596 nuclear replication fork

Up

4.88E-14

8.13E-11

GO:0000775 chromosome, centromeric region

Up

6.55E-14

9.82E-11

Hallmark Category

Direction

HALLMARK_E2f_targets

Up

1.44E-48

7.19E-47

HALLMARK_G2M_checkpoint

Up

8.14E-18

2.03E-16

HALLMARK_epithelial_mesenchymal_transition

Up

2.18565E-05

0.000182137

HALLMARK_DNA_repair

Up

0.001340747

0.009576765

HALLMARK_cholesterol_homeostasis

Up

0.004767588

0.026879478

HALLMARK_estrogen_response_late

Up

0.004838306

0.026879478

HALLMARK_Myc_targets_V1

Up

0.007929791

0.039648953

HALLMARK_mitotic_spindle

Up

0.013387727

0.060853302

HALLMARK_UV_response_up

Up

0.041094641

0.139505466

HALLMARK_apical_junction

Up

0.052624342

0.154777475
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PValue

FDR

PValue

FDR

Table 2.2 Top 10 downregulated Gene Ontology and Hallmark categories at P7
(Enriched in BiNucs at P7)
GO Category

Direction

GO:0044455 mitochondrial membrane part

Down

4.17E-11

3.47E-08

GO:0006099 tricarboxylic acid cycle

Down

5.58E-11

4.40E-08

GO:0070469 respiratory chain

Down

6.97E-11

5.22E-08

GO:0005746 mitochondrial respiratory chain

Down

4.76E-10

2.55E-07

GO:0045333 cellular respiration

Down

1.40E-09

5.39E-07

GO:0005743 mitochondrial inner membrane

Down

1.88E-09

6.71E-07

GO:0006635 fatty acid beta-oxidation

Down

6.45E-09

2.10029E-06

GO:0005747 mitochondrial respiratory chain complex I

Down

1.93E-08

5.35634E-06

GO:0030964 NADH dehydrogenase complex

Down

1.93E-08

5.35634E-06

GO:0045271 respiratory chain complex I

Down

1.93E-08

5.35634E-06

Hallmark Category

Direction

HALLMARK_oxidative_phosphorylation

Down

2.67E-16

4.44E-15

HALLMARK_adipogenesis

Down

8.34E-07

1.04207E-05

HALLMARK_fatty_acid_metabolism

Down

6.47395E-06

6.47395E-05

HALLMARK_bile_acid_metabolism

Down

0.014783457

0.061597739

HALLMARK_protein_secretion

Down

0.030395013

0.116903895

HALLMARK_peroxisome

Down

0.04207603

0.139505466

HALLMARK_heme_metabolism

Down

0.044641749

0.139505466

HALLMARK_myogenesis

Down

0.100500333

0.228409848

HALLMARK_notch_signaling

Down

0.227691276

0.44370498

HALLMARK_p53_pathway

Down

0.239600689

0.44370498
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PValue

PValue

FDR

FDR

Table 2.3 All differentially expressed Gene Ontology and Hallmark categories in
Adult MoNucs versus BiNucs
GO Category

Direction

GO:0000085 G2 phase of mitotic cell cycle

Up

9.08E-08

0.000680188

GO:0051319 G2 phase

Up

9.08E-08

0.000680188

GO:0072329 monocarboxylic acid catabolic process

Down

3.98E-07

0.001050164

GO:0009062 fatty acid catabolic process

Down

4.54E-07

0.001050164

GO:0019395 fatty acid oxidation

Down

5.87E-07

0.001050164

GO:0034440 lipid oxidation

Down

5.87E-07

0.001050164

GO:0018879 biphenyl metabolic process

Up

6.31E-07

0.001050164

GO:0018917 fluorene metabolic process

Up

6.31E-07

0.001050164

GO:0018585 fluorene oxygenase activity

Up

6.31E-07

0.001050164

GO:0006635 fatty acid beta-oxidation

Down

1.50631E-06

0.002256606

GO:0070402 NADPH binding

Down

1.22356E-05

0.015973572

GO:0030258 lipid modification

Down

1.27951E-05

0.015973572

GO:0006733 oxidoreduction coenzyme metabolic
process

Down

3.13271E-05

0.036100915

GO:0003995 acyl-CoA dehydrogenase activity

Down

4.24762E-05

0.045452598

HALLMARK Category

Direction

HALLMARK_fatty_acid_ metabolism

Down

2.16142E-05

0.001080708

HALLMARK_adipogenesis

Down

0.000156879

0.003921965

HALLMARK_epithelial_mesenchymal_transition

Up

0.002099963

0.028172254

HALLMARK_oxidative_ phosphorylation

Down

0.00225378

0.028172254

HALLMARK_bile_acid_ metabolism

Down

0.00377872

0.037787197
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PValue

PValue

FDR

FDR

CHAPTER 3: BINUCLEATION LEADS TO SILENCING OF E2F
TRANSCRIPTION FACTOR ACTIVITY AND IMPAIRS REGENERATIVE
CAPACITY DURING THE NEONATAL PERIOD

3.1 SUMMARY
The data presented in Chapter 2 showed that down-regulation of E2f target genes,
a process that requires Rb, occurs in BiNucs at P7 but is not responsible for inducing
binucleation. In Chapter 3, we examine whether these transcriptional changes instead
occur as a result of binucleation. We utilized a genetic mouse model to alter the ratio of
BiNucs to MoNucs during the neonatal maturation period to establish a direct link
between binucleation and E2f signaling. We also used this genetic model to examine the
relationship between binucleation and loss of regenerative ability in the heart.

3.2 INTRODUCTION
During cytokinesis, the contractile ring is formed beneath the plasma membrane
around the equator of the mitotic cell (Tucker, 1971). It is built by regulatory proteins at
the initiation of cytokinesis, and its constriction carries the plasma membrane with it
towards the cell's center, thus dividing the cell in half. Over a range of cell types and
organisms, the RhoA GTPase pathway is responsible for orchestrating the formation and
contraction of the contractile ring during cytokinesis (Kamijo et al., 2006). Ect2 is the
guanine nucleotide exchange factor (GEF) responsible for activating RhoA and is
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required for successful cytokinesis (Fields and Justilien, 2010; Tatsumoto et al., 1999)
(Figure 3.1). We hypothesized that loss of Ect2 in cardiomyocytes would result in failed
cytokinesis and, therefore, an increase in the proportion of binucleated cardiomyocytes in
the heart during the neonatal period. This model would allow us to draw direct links
between binucleation and its downstream effects.

3.3 LOSS OF ECT2 IN EMBRYONIC CARDIOMYOCYTES RESULTS IN
INCREASED CARDIOMYOCYTE BINUCLEATION AND IS LETHAL
We generated an Ect2flox/flox allele and first crossed it with the cardiomyocytespecific Nkx2.5cre allele. Nkx2.5cre:Ect2flox/flox mice did not survive beyond E10.5 (Figure
3.2A, C, D). At E10.5 Nkx2.5cre:Ect2flox/flox mice had altered myocardial morphology and
a significant decrease in ventricular Ect2 expression (Figure 3.2B-D). E10.5
Nkx2.5cre:Ect2flox/flox mutant hearts were primarily comprised of BiNucs, while control
hearts were comprised almost exclusively of MoNucs. The mean ratio of BiNucs to
MoNucs increased from 0.026 ± 0.01 in control hearts to 3.716 ± 0.07 in mutant hearts.
(Figure 3.2E-F).
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3.4 BINUCLEATION RESULTS IN SILENCING OF E2F TRANSCRIPTIONAL
TARGETS
Next, we crossed our Ect2flox/flox allele with the Mlc2vcre allele. Mlc2vcre shows
cardiomyocyte-specific expression in a mosaic fashion (Gillers et al., 2015; GuimaraesCamboa et al., 2015). We harvested knockout and control hearts at an early and late
neonatal timepoint. At P7, there was no difference in Ect2 expression levels between
Mlc2vcre:R26REYFP and control hearts (Figure 3.3A-B). This is likely because Ect2
expression decreases over the neonatal period, so baseline Ect2 levels would be too low
to observe a difference between the control and knockout animals. Similarly, there was
no difference in the ratio of BiNucs to MoNucs or in the relative expression of E2f target
genes between Mlc2vcre:R26REYFP and control mice at P7 (Figure 3.3C-D). In
Mlc2vcre:R26REYFP hearts, we saw an increase in the proportion of cells expressing YFP
between E18.5 and P2 by FACS, suggesting that cre-mediated recombination increases
during the early neonatal period (Figure 3.4). Therefore, we next examined
Mlc2vcre:Ect2flox/flox mutants at P3, at which time they exhibited a 61.8% decrease in Ect2
expression compared to controls (Figure 3.5A-B). Mlc2vcre:Ect2flox/flox mutants had an
increase in the mean ratio of BiNucs to MoNucs at P3 of 0.901 ± 0.08 compared to 0.339
± 0.02 in control mice (Figure 3.5C-D). QPCR revealed a significant decrease in
expression of E2f target genes in Mlc2vcre:Ect2flox/flox mutants compared to controls but
no significant change in genes that are not E2f targets (Figure 3.5E-F). These data
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suggest that the downregulation of E2f target genes occurs as a direct result of
binucleation in cardiomyocytes.

3.5 BINUCLEATION IMPAIRS REGENERATIVE ABILITY
To examine whether these events impair the regenerative ability of the heart, we
performed LAD ligation to induce myocardial infarction in Mlc2vcre:Ect2flox/flox mutants
and control mice at P1 (Figure 3.6A). At this developmental timepoint, the murine heart
is still able to mount a substantial regenerative response to injury (Porrello et al., 2011).
We observed that at P8, a higher percentage of myocardium remained as scar tissue in
Mlc2vcre:Ect2flox/flox mutants compared to control mice. (Figure 3.6B-C). This data
supports a model whereby binucleation directly results in decreased competency for
proliferation and regeneration via an Rb/E2f pathway.
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3.1 The critical role of Ect2 in cytokinesis
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3.1 The critical role of Ect2 in cytokinesis
Ect2 acts as the Guanine nucleotide exchange factor (GEF) for the RhoA GTPase.
RacGap1 may act as the GTPase activating protein (GAP) for RhoA. RacGap and
MKLP1 form the centralspindlin complex, which recruits Ect2 to the central spindle. The
interaction between centralspindlin and Ect2 is required for Ect2 to be active, which
allows for the location of Ect2 activity to be tightly regulated. Active Ect2 activates
RhoA in a locally precise manner in the overlying cortex by exchanging GDP for GTP.
Active RhoA is responsible for inducing actin polymerization and activating myosin to
form the contractile ring. RhoA is also responsible for regulating the actions of several
additional proteins that induce the contraction of the contractile ring leading to cleavage
furrow formation and ingression.
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Figure 3.2 Loss of Ect2 in the embryonic heart results in binucleation of
cardiomyocytes and is lethal
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Figure 3.2 Loss of Ect2 in the embryonic heart results in binucleation of
cardiomyocytes and is lethal
(A) Timecourse of Ect2 knockout using Nkx2.5cre. (B) Expression values of the Ect2
transcript in Nkx2.5cre:Ect2flox/flox (HOM) samples compared to Ect2flox/flox and Ect2flox/+
(WT) samples at E10.5 by qPCR. Data are mean ± SEM. n=5-6 animals per group (C-D).
Representative tissue sections of WT and HOM hearts at E10.5 and E11.5 stained with
H&E (C) or an antibody against cardiac Troponin T (D) reveals that the
Nkx2.5cre:Ect2flox/flox allele is lethal by E11.5. Scale bar, 100 μm. (D) Representative
images of a MoNuc and BiNuc present in E10.5 HOM samples. Single-cell suspensions
were cytospun and stained with an antibody against α-actinin. Scale bar, 20 μm. (E)
Quantification of the ratio of BiNucs to MoNucs and percentages of MoNucs and BiNucs
in E10.5 WT and HOM samples. Data are mean ± SEM. n=3 animals per group. p-values
are determined by student’s t-test. ns=not significant, *=p<0.05, **=p<0.01,
***=p<0.001, ****=p<0.0001.
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Figure 3.3 By P7, no differences are observed between Mlc2vcre:Ect2flox/flox and
control mice
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Figure 3.3 By P7, no differences are observed between Mlc2vcre:Ect2flox/flox and
control mice
(A) Timecourse of the first set of experiments knocking out Ect2 with Mlc2vcre. (B)
Expression values of the Ect2 transcript in Mlc2vcre:Ect2flox/flox (HOM) samples compared
to Ect2flox/flox and Ect2flox/+ (WT) samples at P7 by qPCR. Data are mean ± SEM. n=6
animals per group. (C) Quantification of the ratio of BiNucs to MoNucs and percentages
of MoNucs and BiNucs in P7 WT and HOM samples. Quantification of MoNucs and
BiNucs was done by FACS. Data are mean ± SEM. n=3 animals per group. (D) Gene
expression differences between WT and HOM samples of E2f target genes at P7. Data
are mean ± SEM. n=6 animals per group. p-values are determined by student’s t-test.
ns=not significant.
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Figure 3.4 Mlc2vcre recombination increases during the early neonatal period
FACS plots of YFP presence in cells from Mlc2vcre:R26REYFP hearts at E18.5 and P2
show an increase in YFP+ cells between E18.5 and P2. This suggests that Mlc2vcre
recombination occurs in at least a subset of cardiomyocytes during the neonatal period.
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Figure 3.5 Mlc2vcre:Ect2flox/flox results in increased binucleation at postnatal day 3
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Figure 3.5 Mlc2vcre:Ect2flox/flox results in increased binucleation at postnatal day 3
(A) Timecourse of the second set of Ect2 knockout experiments using Mlc2vcre. (B)
Expression values of the Ect2 transcript in Mlc2vcre:Ect2flox/flox (HOM) samples compared
to Ect2flox/flox and Ect2flox/+ (WT) samples at P3 by qPCR. Data are mean ± SEM. n=5-6
animals per group. (C) Images of P3 HOM MoNuc and BiNuc cardiomyocytes from
fixed single-cell suspensions stained with anti-α-actinin. Scale bar, 20 μm. (D)
Quantification of the ratio of BiNucs to MoNucs and percentages of MoNucs and BiNucs
in P3 WT and HOM samples. Data are mean ± SEM. n=3 animals per group. (E) Gene
expression differences between WT and HOM samples of E2f target genes and non-E2f
target genes. Data are mean ± SEM. n=5-6 animals per group. p-values are determined by
student's t-test. ns=not significant, *=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001.
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Figure 3.6 Neonatal binucleation impairs regenerative potential
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Figure 3.6 Binucleation impairs regenerative potential
(A) Schematic showing study design of MI by ligation of the left anterior descending
(LAD) artery in Mlc2vcre:Ect2flox/flox mutant and control mice at P1. (B) Masson’s
trichrome–stained heart sections from the ligation site toward the apex 7 days after injury.
n=6 per group (C) Quantification of the percent of left ventricular myocardium
containing scar tissue at P8. The suture location is indicated with a purple arrow. Scar
boundaries are indicated with black arrows. Scale bar, 500 μm. Data are mean ± SEM.
n=6 animals per group. p-values are determined by the Mann-Whitney U test. ns=not
significant, *=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001.
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS

4.1 DISCUSSION
A lack of effective therapeutic strategies to treat the acutely injured heart has led
scientists to search for a means to replace cardiomyocytes that have been lost due to
injury. One compelling approach would be to develop therapies that activate endogenous
cardiomyocyte proliferation to regenerate damaged tissue. While previous work has
suggested a correlation between cardiomyocyte nucleation and the ability to re-enter the
cell cycle, with MoNucs being more receptive to proliferative stimuli, the molecular basis
for this difference has remained elusive, likely due to the technical hurdles in isolating
and independently characterizing MoNucs and BiNucs. To address this question, I
developed a novel FACS-based strategy to isolate these two cardiomyocyte populations
at embryonic, neonatal, and adult timepoints. This methodological advancement allowed
us to carry out the first characterization of the molecular differences between MoNucs
and BiNucs. It will also allow for continued future work toward better understanding the
differences between these two cardiomyocyte subsets. Furthermore, I expanded this
FACS based approach to sort total adult cardiomyocytes without the use of a lineage
label. This strategy takes advantage of the large size and unique shape of cardiomyocytes
to separate them from the other cell types in the heart based on the same principles
underlying the separation of MoNucs from BiNucs.

78

The MoNuc and BiNuc cardiomyocyte subsets diverge during a neonatal period
during which time cardiomyocytes exit the cell cycle and undergo terminal
differentiation. I examined the transcriptional profiles of MoNucs and BiNucs at
developmental timepoints before, during, and after this neonatal transition period. We
chose these timepoints to gain insight into how the two cardiomyocyte populations
diverge and how their processes of cell cycle exit and maturation may differ. Our data
revealed that MoNucs and BiNucs are most distinct during the neonatal period, as these
subsets begin to diverge. At P7, binucleation was associated with the termination of a
proliferation-associated gene expression program in exchange for a mature
cardiomyocyte gene expression program. While this programmatic switch has long been
associated with the neonatal period, our findings show that by P7, only BiNucs have
begun to undergo this shift, while MoNucs remain transcriptionally immature. While our
data show that MoNucs eventually assume a similar mature gene expression program, it
appears to do so at a later time, and not as a result of binucleation. These findings raise
the possibility that the mechanism that couples binucleation to the observed
transcriptional shift also contributes to the increased loss of proliferative competency
observed in BiNucs.

E2f target genes comprise a large portion of the most dramatically downregulated genes in P7 BiNucs, some of which remain down-regulated in adult BiNucs.
The E2f transcription factor family is known to regulate the expression of genes required
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to initiate DNA synthesis (Johnson et al., 1993). While cardiomyocytes continue to
undergo hypertrophic growth after the neonatal maturation period, the S phase is the
earliest phase of the cell cycle they do not enter under physiological conditions. E2f
activity is known to be regulated by Rb, and this interaction can have temporary, as well
as long term control over entry into S phase (Harrington et al., 1998; Lundberg and
Weinberg, 1998; Nevins, 1992). Rb mediated silencing of E2f target genes is involved in
irreversible exit of the cell cycle during senescence, leaving cells unable to respond to
proliferative stimuli (Narita et al., 2003). While the phosphorylation state of Rb dictates
temporary repression of S phase entry during the cell cycle, other post-translational
modifications to Rb regulate its ability to irreversibly terminate the cell cycle (Kwon et
al., 2017; Markham et al., 2006; Saddic et al., 2010). Previous work has also shown that
Rb family members are required for cell cycle exit of cardiomyocytes during the
postnatal period (MacLellan et al., 2005). This offers an intriguing potential mechanism
by which the binucleation process could be coupled to irreversible cell cycle exit.

We knocked out Rb in vitro in neonatal cardiomyocytes to examine its role in
binucleation and the depletion of E2f target genes we observed in P7 BiNucs. While the
loss of Rb family members did not result in a difference in the ratio of BiNucs to
MoNucs, it did result in increased expression of E2f target genes depleted in P7 BiNucs.
This places Rb downstream of binucleation and shows that in neonatal cardiomyocytes,
Rb is required for down-regulating E2f target gene expression.
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In Chapter 3 of this dissertation, I showed that we could alter the ratio of BiNucs
to MoNucs during both the embryonic and neonatal periods by knocking out Ect2 in the
heart. By altering the ratio of BiNucs to MoNucs during the neonatal maturation period,
we demonstrated that increased binucleation at P3 led to decreased expression of E2f
target genes. This data supports the hypothesis that Rb mediated silencing of E2f target
genes during the neonatal period is a direct result of binucleation. Recent work from
Hirose et al. further supports the direct connection we observed between binucleation and
E2f target gene expression. This work shows that increasing the percentage of diploid
MoNucs by expression of a dominant negative thyroid hormone receptor-a is associated
with the upregulation of E2f signaling and downregulation of oxidative phosphorylation
gene expression (Hirose et al., 2019).

We also used our Ect2 knockout model to show a direct connection between
binucleation and regeneration after injury in the murine heart. Increased binucleation
during the neonatal period was accompanied by impaired regeneration after ligation of
the left anterior descending artery. This data suggests that the loss of regenerative
competency is a result of the binucleation process.

4.2 FUTURE DIRECTIONS
In work detailed in this dissertation, I aimed to investigate a link between
binucleation and loss of ability to re-enter the cell cycle. Over the last few years, several
81

new reports have shown that this connection is biologically meaningful, and it has
quickly become an important focus in efforts to modulate the regenerative abilities of the
heart. The work presented in this dissertation begins to fill in details of the mechanism
that connects binucleation to loss of regenerative capacity and, in doing so, raises several
new exciting questions and possibilities. It is my hope that the questions outlined below
are included among those focused on in future work.

As a result of binucleation, does Rb mediate epigenetic changes responsible for the loss
of proliferative competency?
The data presented in Chapters 2 and 3 of this dissertation point to a key role for
the Rb/E2f pathway in mediating the link between binucleation and loss of proliferative
competency. This possibility is supported by the known roles of the Rb/E2f pathway in
regulating permanent cell cycle exit. In senescent cells, regulation of irreversible cell
cycle exit by Rb includes the recruitment of chromatin-modifying proteins that alter the
architecture of E2f target genes (Blais et al., 2007; Frolov and Dyson, 2004). CpG
methylation changes and histone modifications to E2f target genes are also known to
occur during the process of cardiomyocyte maturation (Gilsbach et al., 2018; Sdek et al.,
2011). Recent work showed that E2f transcription factor networks are among those that
undergo extensive chromatin remodeling during the postnatal period and therefore fail to
reactivate in adult cardiomyocytes after injury (Quaife-Ryan et al., 2017). Therefore, our
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data, together with our current understanding of the Rb/E2f pathway, strongly suggests
that Rb may mediate epigenetic changes as a result of binucleation. This offers an
intriguing explanation for the results presented in this dissertation, and future work will
be necessary to examine this possibility.

What is the functional relevance of the differences we observed between adult MoNucs
and BiNucs?
We observed that adult MoNucs and BiNucs retain remnants of some of the
differences established during the neonatal period, including differences in E2f target
gene expression. Rb mediated differences in the chromatin state of E2f target genes
would not only provide an explanation for the differences in proliferative competencies
observed between adult MoNucs and BiNucs, but it would also offer a potential
explanation for the modest transcriptional differences we observed in E2f target genes
between Adult MoNucs and BiNucs. These minor differences in transcript levels of genes
that are largely not expressed in this context may not be responsible for functional
differences but instead be a reflection of epigenetic differences between the two cell
types.

Furthermore, we observed by electron microscopy that adult MoNucs and BiNucs
appear to have different densities of glycogen granules. This suggests that MoNucs and
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BiNucs may have differences in energy utilization or storage. Future work will be
necessary to better understand whether there are indeed metabolic differences between
adult MoNucs and BiNucs. Furthermore, if there are differences, it remains to be
determined whether they contribute to discrepancies in proliferative competency.

Is a specific set of conditions required to pair the binucleation process to loss of
proliferative competency?
Interestingly, induced binucleation via loss of Ect2 led to E2f target gene
inhibition at P3 but not at E10.5. We also did not see the same degree of a transcriptional
switch in BiNucs at E18.5 compared to BiNucs at P7. Taken together, this suggests that
conditions present during the neonatal period, but not the embryonic period, may act to
couple binucleation with depletion of E2f target genes. Previous research suggests that
the increase in environmental oxygen following birth results in DNA damage by reactive
oxygen species. These events have been proposed to initiate the cell cycle exit of
cardiomyocytes (Puente et al., 2014). DNA damage-associated cell cycle exit has been
observed to be mediated by methylated or acetylated Rb (Markham et al., 2006; Saddic et
al., 2010). Perhaps these events must occur in order for binucleation to be paired to the
transcriptional switch we observed to occur during the neonatal but not embryonic
period. Future work would be needed to examine whether a set of upstream conditions
are required for binucleation to result in the transcriptional shift we observed. The answer
to this question may offer valuable insight into how these events are linked and whether
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they could be unlinked for the purposes of increasing the proliferative competency of
cardiomyocytes.

How do our results apply to the human heart?
While a majority of adult murine cardiomyocytes are binucleated, the majority of
adult cardiomyocytes in the human heart are thought to be mononucleated and polyploid
(Bergmann et al., 2011; Brodsky et al., 1980). Therefore, the applicability of our findings
to the human heart remains to be determined. However, the processes resulting in
binucleation and polyploidy share similarities, and both can result from failed cell
division, whether at the karyokinesis stage or the cytokinesis stage. Karyokinesis and
cytokinesis are tightly coupled processes and are orchestrated by a shared group of
molecular regulators (Jeyaprakash et al., 2007; McCollum, 2004). Therefore, it is
possible that whether destined to become polyploid or binucleated, human and mouse
cardiomyocytes share similar molecular mechanisms responsible for, and in response to,
failure of cardiomyocytes to complete cell division. First, however, it should be
determined whether mononucleated diploid cardiomyocytes in the human heart retain
increased proliferative and regenerative competency compared to polyploid and
binucleated cardiomyocytes. Work in zebrafish shows that induced binucleation and
polyploidy impairs cardiac regeneration, and we showed that this holds true in the mouse
heart as well. This would suggest that the link between binucleation or polyploidy and
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loss of proliferative competency is conserved over evolution, but future experiments will
be necessary to confirm whether this is the case.

4.3 CONCLUDING REMARKS
In this dissertation, I described a novel method to separate mononucleated and
binucleated cardiomyocytes, which allowed for the first characterization of the
differences between these two cell types. The data presented here provide evidence of a
direct link between the binucleation process and the termination of a transcriptional
program associated with proliferation. Furthermore, this analysis suggests that an E2f/Rb
transcriptional network is centrally involved in the divergence of mononucleated and
binucleated cardiomyocytes. This work suggests a potential mechanism by which
binucleation may result in loss of regenerative capacity and provides a tool that will allow
for further investigations to build on these findings.
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CHAPTER 5: METHODS AND MATERIALS

5.1 EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
R26REYFP (Jackson Labs; cat# 006148) (Srinivas et al., 2001), ROSA26FLPe (Jackson
Labs; cat# 009086) (Farley et al., 2000), Nkx2.5cre (Jackson Labs; cat# 024637) (Stanley
et al., 2002), and Mlc2vcre (Jackson Labs; cat# 029465) (Chen et al., 1998) mice were
purchased from Jackson Labs and have been previously described. To generate the
Ect2flox/flox allele, cryopreserved sperm from the Ect2tm1a(EUCOMM)Wtsi mouse line was
purchased from the Institut Clinique de la Souris (Illkirch, France). The mouse line was
derived through in-vitro fertilization by the Transgenic and Chimeric Mouse Facility at
the University of Pennsylvania. The resulting mouse was then bred with the ROSA26FLPe
allele to remove the neomycin cassette and generate a conditional allele with LoxP sites
flanking exon 13 (Figure 5.1). For cardiomyocyte sorting experiments, Adult (8-13
weeks), P7, or E18.5 Mlc2vcre/+:R26REYFP/+ offspring were generated by breeding female
R26REYFP/EYFP mice with Mlc2vcre/+ males. For Ect2 experiments, Ect2flox/flox mice were
bred to either Mlc2vcre/+ or Nkx2.5cre/cre to generate mice heterozygous for both alleles.
Resulting mice were then bred with Ect2flox/+ mice to generate litters used in experiments.
A mix of male and female age-matched and litter-matched healthy mice were used for all
experiments. No animals were used for more than one experiment. Animals were housed
in breeding pairs or with sex-matched littermates in the small animal vivarium at the
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Smilow Center for Translational Research at the Perelman School of Medicine and
maintained in a 12-h light, 12-h dark cycle with unlimited access to food and water. DNA
isolation for genotyping was performed by digesting tails in 50 μL Tris-EDTA, pH8 for 5
minutes at 95°C followed by the addition of 47 μL Tris-EDTA with 3 μL of a 10 mg/ml
stock of Proteinase K. The mixture was then incubated for 3 hours at 55°C followed by 5
minutes at 95°C. Genotyping was performed using the primers in Table 5.1. All animal
procedures were approved by the University of Pennsylvania Institutional Animal Care
and Use Committee under protocol #806345.

5.2 LABORATORY METHODS
Isolation of Mouse Cardiomyocytes
Isolation of Adult Cardiomyocytes
Cardiomyocytes were isolated from mice aged 8-13 weeks using a protocol modified
from methods previously described (Judd et al., 2016; Robison et al., 2016; Tian et al.,
2015). Buffers were prepared on the day of isolation as follows. Cell Isolation Buffer
(CIB): 130 mM NaCl (Sigma; S6191), 1 mM Lactic acid (Sigma; L1750), 5.4 mM KCl
(Sigma; P3911), 25 mM HEPES (Bioworld; 0820000-3), 0.50 mM MgCl2 (Sigma;
M9272), 0.33 mM NaH2PO4 (Sigma; S9638), 22 mM Glucose (Sigma; 16301), 20 mM
Creatine Monohydrate (GNC; 350526), brought to pH 7.4 with 10M NaOH. 10X CIB
stock excluding Glucose, Creatine, and NaOH was previously prepared and frozen in
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aliquots; Digestion buffer: CIB with 60 U/mL Collagenase Type II (Worthington;
LS004176) and 0.025 mg/mL Protease Type XIV (Sigma; P5147); Dissociation Buffer:
CIB with 1 mg/mL BSA (Omnipor; 2960). Mice were injected with 100 USP units
Heparin (Abraxis; 401586B) 25 minutes prior to removal of the heart. Mice were
terminally anesthetized with Isoflurane, and the heart was removed and placed in ice-cold
CIB. The heart was cannulated via the aorta, secured with 5-0 silk suture, and mounted
on a Langendorf apparatus. The heart was then perfused with CIB for 3 min at a
temperature of 37°C and a constant flow rate of 3 ml/min, followed by perfusion with
Digestion Buffer for 14 minutes. The ventricles were then removed from the Langendorf
apparatus and placed in Dissociation Buffer at a temperature of 37°C and gently teased
apart with forceps. Tissue was then triturated with a transfer pipette, and the cell
suspension was passed through a 100 μm cell strainer. To begin gradually adding back
calcium, an equal volume of Dissociation Buffer supplemented with 200 μM Ca2+ was
then added dropwise to the cell suspension. Cardiomyocytes were enriched by
centrifugation at 300 RPM for 3 min and resuspended in Dissociation Buffer
supplemented with 250 μM Ca2+. Cardiomyocytes were then allowed to settle by gravity
sedimentation for 20 minutes at 37°C and resuspended in 4 mL Dissociation Buffer with
500 μM Ca2+.
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Isolation of P7 Cardiomyocytes
Buffers were prepared on the day of isolation as follows. Cell Isolation Buffer (CIB) was
the same as used for isolation of adult cardiomyocytes; P7 Digestion Buffer: CIB with
506 U/mL Collagenase Type II and 0.52 mg/mL Trypsin (Fisher; J63993, 1:250); P7
Dissociation Buffer: CIB with 506 U/mL Collagenase Type II and 0.52 mg/mL Trypsin,
10% Horse Serum (Gibco; 16050), 5% Fetal Bovine Serum (Gibco; 10437); P7 Sort
Buffer: CIB with 0.66% Horse Serum, and 0.33% Fetal Bovine Serum. Hearts were
removed from 7-day-old mice and placed in ice-cold CIB. YFP+ hearts were identified
and used for cell isolation. Under a dissection microscope, atria and extraneous tissue
were removed, and ventricles were cut into fourths. Each heart was then placed in 2 mL
P7 Digestion Buffer and incubated for 30 minutes at 37°C with rocking. Each heart was
then transferred to 2 mL P7 Dissociation Buffer supplemented with 60 μM Ca2+, where it
was triturated with a transfer pipette followed by a 1000 μL pipette tip. Cell suspensions
were then combined and passed through a 70 μm cell strainer. The cell suspension was
then centrifuged twice for 5 minutes at 500 RPM and resuspended first in P7 Dissociation
Buffer supplemented with 140 μM Ca2+, then in 4 mL P7 Sort Buffer supplemented with
240 μM Ca2+. VybrantTM DyeCycleTM Violet was added to the cell suspension at 1
μL/mL, and cells were incubated at 37°C for 30 minutes prior to FACS.
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Isolation of E18.5 Cardiomyocytes
Buffers were prepared on the day of isolation as follows. E18.5 Digestion Buffer: HBSS
(Gibco; 14170) with 10 mM HEPES (Invitrogen; 15630), 0.54 mM EDTA (Invitrogen;
15575) and 2 mg/mL Trypsin; E18.5 Dissociation Buffer: HBSS with 10mM HEPES,
10% Horse Serum, 5% Fetal Bovine Serum; E18.5 Sort Buffer: Opti-MEM (Gibco;
31985) with 0.66% Horse Serum, and 0.33% Fetal Bovine Serum. Time pregnant females
were euthanized by CO2 inhalation. Embryos were removed, and hearts were excised and
placed in ice-cold HBSS. YFP+ hearts were identified and used for cell isolation. Under
a dissection microscope, atria and extraneous tissue were removed, and ventricles were
splayed open. Each heart was then placed in 2 mL E18.5 Digestion Buffer and incubated
for 10 minutes at 37°C with rocking. Each heart was then transferred in a drop of
Digestion buffer to a well of a 12 well plate and incubated for 30 minutes. 2 mL E18.5
Dissociation Buffer was then added to each well, and the heart was triturated with a 1000
μL pipette tip. Cell suspensions were then combined and passed through a 70 μm cell
strainer. The cell suspension was then centrifuged for 5 minutes at 500 RPM and
resuspended in 4 mL E18.5 Sort Buffer. VybrantTM DyeCycleTM Violet was added to the
cell suspension at 1 μL/mL, and cells were incubated at 37°C for 30 minutes prior to
FACS.
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Sorting Mononucleated and Binucleated Cardiomyocytes by FACS
VybrantTM DyeCycleTM Violet (Invitrogen; V35003) was added to cell suspensions at 1
μL/mL and incubated at 37°C for 30 minutes prior to FACS. Cell sorting was performed
on a MoFlo Astrios EQ (Beckman Coulter) at room temperature. Embryonic and neonatal
cardiomyocytes were sorted using a 100 um nozzle, while adult cardiomyocytes were
sorted using a 150 um nozzle with a maximum pressure difference of 1. Cardiomyocytes
from Mlc2vCre:R26REYFP mice were gated on YFP presence with a 488 nm laser.
Nucleation was gated on the height and width of the signal from a 405 nm laser as
described above. Prior to collection, 50-100 cells within each gate were sorted onto a
slide and imaged with the DAPI, GFP, and transmitted light channels of an EVOS FL
Auto imaging system microscope (ThermoFisher; AMAFD1000) to ensure correct
separation of mononucleated and binucleated cells. If necessary, gates were adjusted until
the targeted cells were correctly identified. For RNA, an equal number of mononucleated
and binucleated cardiomyocytes were sorted into Trizol-LS (LifeTech; 10296028).

RNA Isolation for RNA-seq and qPCR
RNA was isolated by phenol-chloroform extraction followed by precipitation with 75%
Ethanol. RNA was then purified using the RNeasy micro Kit (Qiagen; 74004) as follows.
A solution containing precipitated RNA was applied to an RNeasy MinElute Spin
Column, and washes were done according to the manufacturer's protocol. RNA was then
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eluted in 20 μL H2O. RNA to be sequenced was tested for integrity via Bioanalyzer using
the RNA 6000 Pico Kit (Agilent; 5067). RNA for qPCR was quantified using a
Nanodrop One (Thermo), and cDNA was generated using the Superscript IV First-Strand
Synthesis System (ThermoFisher; 18090050). Quantitative Real-Time PCR was
performed on a QuantStudio 7 Flex with Power SYBR Green PCR Mastermix (Applied
Biosystems; 4367659). QPCR primer sequences are listed in Table 4.2.

Surgical Procedures
To induce MI in neonatal mice, we permanently ligated the LAD artery on postnatal day
1 (P1) as previously described (Leach et al., 2017). To minimize stress and reduce the
likelihood of the pups being rejected by the nursing dam, only half of the litter was
removed prior to commencing surgery. Pups were housed in an incubation chamber to
provide warmth throughout and after the surgical procedure. The dam was housed away
from the operating table during the procedure. P1 mice were anesthetized by cooling on
ice. Once the appropriate plane of anesthesia is reached, the neonate was removed from
the ice for the surgical procedure. Appropriate anesthesia was recognized by a lack of
breathing, movement, and reflexes. The pup was placed atop a firm operating surface in
the supine position. Forelimbs and tail were held in position using masking tape. A
dissecting microscope with a fibro-optic light was used for visualization throughout the
surgery. A lateral skin incision was then made on the left side of the chest, just below the
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insertion of the left forelimb, using fine scissors and forceps. Blunt dissection was used to
expose the ribs, and a lateral thoracotomy was performed at the fourth intercostal space
by blunt dissection of the intercostal muscles following skin incision. The left anterior
descending coronary artery (LAD) was identified under the microscope. 8-0 nylon suture
was then sutured across the LAD and permanently ligated. The visualization of the
whitish color of the left ventricular apex assured the effective ligation of LAD. Following
the LAD ligation, the thoracotomy was closed by re-approximating the ribs using a 6-0
non-absorbable suture. The skin incision was then closed using Vetbond, a skin adhesive
glue. The entire procedure took less than 10 minutes per mouse. The instruments were
sterilized between procedures using a hot bead sterilizer. After surgery, pups were
brought back to body temperature by placing them in a 33C incubator for 20-30 minutes.

In vitro Experiments
Cardiomyocytes were isolated from Rbflox/flox;p130flox/flox;p107-/- pups at postnatal day 1.
Buffers and protocol were as described for isolating E18.5 cardiomyocytes with the
following modifications. Rinse buffer: DMEM with 10% Horse Serum, 5% Fetal Bovine
Serum, 1% Pen/Strep. High Serum Culture Media: Opti-MEM with 10% Horse Serum,
5% Fetal Bovine Serum, 1% Pen/Strep. Low Serum Culture Media: Opti-MEM with
0.7% Horse Serum, 0.3% Fetal Bovine Serum, 1% Pen/Strep. Each heart was placed in 2
mL Digestion Buffer and incubated overnight at 4°C with rocking instead of 10 minutes
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at 37°C. Following dissociation, cell suspensions were washed with Rinse Media, then
resuspended in High Serum Culture media and passed through a 70 μm cell strainer.
Fibroblasts were depleted by plating cell suspensions for 2 hours on cell culture plastic.
Cell suspensions were then collected, and cells counted with a hemocytometer. 75,000
cells in High Serum Culture Media were plated in per well of a 48 well plate, precoated
overnight with 100

g/mL laminin. The following day, each well of cells was treated

with 5x10^6 PFU of adenovirus expressing either GFP (Ad-GFP) (Vector Biolabs; 1060)
or both Cre recombinase and GFP (Ad-Cre-GFP) (Vector Biolabs; 1700). The morning
after adenoviral infection, media was changed to Low Serum Culture Media for 24 hours
to inhibit the growth of fibroblasts. 36 hours after adenoviral infection, media was
changed back to High Serum culture media, and cells were cultured for an additional 36
hours. 72 hours after adenoviral infection, cells were harvested in Trizol for RNA as
described above or fixed for staining to quantify nucleation.

Histology and Immunostaining
Single-cell suspensions of cardiomyocytes were fixed in 4% PFA and permeabilized in
PBS with 0.5% TritonX-100. SEA BLOCK blocking buffer (ThermoFisher; 37527) was
used for blocking, diluting antibodies, and washes. Cells were incubated with primary
antibody overnight at 4°C, followed by the secondary antibody for 1 hour at room
temperature. Cells were then incubated with DAPI, pelleted, resuspended in ProLong
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Diamond Antifade Mountant (ThermoFisher; P36961), and mounted on slides. Images
were acquired with the Nikon Eclipse Ni-E microscope, and mononucleated and
binucleated cells were counted using Fiji Software. Histology was performed by
members of the Penn Cardiovascular Institute's Histology and Gene Expression Core
Facility. For Histology, tissues were fixed in 4% paraformaldehyde, dehydrated through a
series of ethanol washes, and embedded in paraffin. Tissue was sectioned at 6 μm
intervals and stained with either hematoxylin and eosin, Masson’s trichrome, or by
immunostaining. Primary antibody information and concentrations used are listed in
Table 4.3.

Electron Microscopy
Cardiomyocytes for electron microscopic examination were sorted directly into fixative
containing 2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1M sodium cacodylate
buffer, pH 7.4, overnight at 4°C. After subsequent buffer washes, the samples were postfixed in 2.0% osmium tetroxide for 1 hour at room temperature and rinsed in DH2O prior
to en bloc staining with 2% uranyl acetate. After dehydration through a graded ethanol
series, the tissue was infiltrated and embedded in EMbed-812 (Electron Microscopy
Sciences, Fort Washington, PA). Thin sections were stained with uranyl acetate and lead
citrate and examined with a JEOL 1010 electron microscope fitted with a Hamamatsu
digital camera and AMT Advantage image capture software.
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5.3 QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis
Data are reported as Mean ± SEM. Statistical analysis was performed in Prism 7 for Mac.
Unless otherwise specified, an unpaired Student's t-test was used to compare two
experimental groups. For injury studies, a Mann-Whitney U test was used. Data were
considered significant if p < 0.05.

Quantification of Scar Size
Scar size was measured as the percent fibrosis of the left ventricle myocardium from the
site of the suture to the apex using MIQuant, an automated image segmentation opensource code for MATLAB (Nascimento et al., 2011). The average of two independent
measurements of scar size is reported. The initial measurement was not obtained blind; to
ensure reproducibility, a second investigator measured scar size blind to genotype.

RNA-Sequencing and Analysis
Library prep was conducted using Illumina truSeq stranded mRNA kit and Clontech
SMARTer RNA-seq ampliﬁcation kit. Fastq ﬁles were assessed for quality control using
the FastQC program. Fastq ﬁles were aligned against the mouse reference genome (mm9)
using the STAR aligner (Dobin et al., 2013). Duplicate reads were ﬂagged using the
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MarkDuplicates program from Picard tools. Per gene read counts for Ensembl (v67) gene
annotations were computed using the R package with duplicate reads removed. Gene
counts represented as counts per million (CPM) were ﬁrst nominalized using TMM
method in the edgeR R package, and genes with 25% of samples with a CPM < 1 were
removed and deemed low expressed. The data were transformed using the VOOM
function from the limma R package (Law et al., 2014). Differential gene expression was
performed as a paired analysis between mono-nuclear and bi-nuclear samples using
limma. To perform the pair-wise test, the subject correlation was first computed using
duplicate Correlation() function, and the linear model was then fit using the subject as a
blocking variable and adjusting for the subject correlation. Given the small sample size of
the experiment, we employed the empirical Bayes procedure as implemented in limma to
adjust the linear fit and calculate p-values. p-values were adjusted for multiple
comparisons using the Benjamini-Hochberg procedure. Heatmaps and PCA plots were
generated in R. Gene Ontology enrichment analysis was performed using the ToppGene
Suite (https://toppgene.cchmc.org/) (Chen et al., 2009).

Data and Code Availability
The sequencing data in this manuscript are available on GEO through the accession
number: GSE140851
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Figure 5.1 Generation and genotyping of the floxed Ect2 allele
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Figure 5.1 Generation and genotyping of the floxed Ect2 allele
A mouse line containing the targeted allele was derived through in-vitro fertilization by
the Transgenic and Chimeric Mouse Facility at the University of Pennsylvania.
Genotyping of tails from mice containing the targeted allele with the Kr and Ef primers
resulted in amplification of a 318 bp PCR product. Once the neomycin cassette is
removed by breeding to a ROSA26FLPe allele, genotyping of the conditional allele with
the Ef and Er primers will generate a PCR product of 502 bp whereas the wild type allele
will generate and PCR product of 402 bp. Figure was adapted from literature provided by
the Institut Clinique de la Souris.

100

Table 5.1 Genotyping primer sequences

Primer

Sequence

Ect2-Ef

ATTGTCACTCATGCTAGGGAGGTGC

Ect2-Er

CGTGTGAAGTTCTAGGCTCAACCACAA

Ect2- Kr

CCAACAGCTTCCCCACAACGG

Mlc2vcre Fwd

CCAGGGGAGAGGTATTTATTGTTCC

Mlc2vcre Rev

CCAGGTATGCTCAGAAAACGCC

Nkx2.5cre Fwd

CGTTTTCTGAGCATACCTGGA

Nkx2.5cre Rev

ATTCTCCCACCGTCAGTACG

R26REYFP mut Fwd

AAGGGAGCTGCAGTGGAGTA

R26REYFP mut Rev

CCGAAAATCTGTGGGAAGTC

R26REYFP wt Fwd

ACATGGTCCTGCTGGAGTTC

R26REYFP wt Rev

GGCATTAAAGCAGCGTATCC
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Table 5.2 qPCR primer sequences
Gene

Sequence

E2f1 Fwd

GGGAGAAGTCACGCTATGAAACCT

E2f1 Rev

ATGTCATAGATGCGCCGTTTCTGC

Mcm2 Fwd

AACTGTAGCAAGTGCAACTTTGT

Mcm2 Rev

GCGGATACGTTGGTAGTTCTGAT

Ccne2 Fwd

ATGTCAAGACGCAGCCGTTTA

Ccne2 Rev

GCTGATTCCTCCAGACAGTACA

Top2a Fwd

CGAGCAAGAAAGCAAAGGG

Top2a Rev

CTTAATTGGCTTCCTCGCC

Ccne1 Fwd

AGCGAGGATAGCAGTCAGCC

Ccne1 Rev

GGTGGTCTGATTTTCCGAGG

Mcm6 Fwd

CCTGTGAATAGGTTCAACGGC

Mcm6 Rev

CATTTTCCTGAGGTGGAGCAC

Cdt1 Fwd

ACAGCCGGGCAAGATCCCCT

Cdt1 Rev

GGCTCCCAACTTCCGTGCCC

Rfc2 Fwd

CTGCCGTGGGTTGAAAAATACA

Rfc2 Rev

CAGAGGATGCTGGTTGTCTTG

Pcna Fwd

TTTGAGGCACGCCTGATCC

Pcna Rev

GGAGACGTGAGACGAGTCCAT

Cdk5 Fwd

CCCTGAGATTGTGAAGTCATTCC

Cdk5 Rev

CCAATTTCAACTCCCCATTCCT

Myh7 Fwd

GAGCCTTGGATTCTCAAACG

Myh7 Rev

GTGGCTCCGAGAAAGGAAG

Rb1 Fwd

TGCATCTTTATCGCAGCAGTT

Rb1 Rev

GTTCACACGTCCGTTCTAATTTG

Necdin Fwd

GGCGCTCAACAACCGTATG

Necdin Rev

CTCGGTGATTATCTTCCTCACG

Cenpf Fwd

GCACAGCACAGTATGACCAGG

Cenpf Rev

CTCTGCGTTCTGTCGGTGAC

Ect2 Exon13 Fwd

TACTCCAGTTCCTCCAAAGCAG

Ect2 Exon13 Rev

GTCCTTCTTCTTCTAAGGGCACC

Gapdh Fwd

TGCACCACCAACTGCTTAGC

Gapdh Rev

GGCATGGACTGTGGTCATGAG
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Table 5.3 Primary antibodies used for immunostaining
Antibody

Species

Company

Catalog #

Dilution

Sarcomeric α-Actinin
Troponin T-C
GFP
Phospho-Histone H3
Aurora B Kinase
Ki67
PCM1

Mouse
Goat
Goat
Rabbit
Rabbit
Rabbit
Rabbit

Sigma
Santa Cruz
Abcam
Cell Signaling
Abcam
abcam
Sigma

A7811
sc-8121
ab6673
9701
ab2254
ab16667
HPA023370

1:100
1:25
1:500
1:150
1:1000
1:50
1:100
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